Patents by Inventor Shaoyu XU

Shaoyu XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11899227
    Abstract: The present disclosure provides a solar reflecting film and a preparation method thereof. The solar reflecting film includes a substrate and a functional layer stacked on each other. The functional layer includes a first reflecting layer, a barrier layer, and a second reflecting layer stacked on the substrate in order. The barrier layer includes a first barrier layer and a second barrier layer stacked on the first barrier layer. The first barrier layer is metal fluoride, inorganic non-metallic oxide, metal oxide or a combination thereof. The second barrier layer is metal oxides, metal nitrides, semiconductor doped compounds or a combination thereof. And a material of the first barrier layer is at least partially different from that of the second barrier layer.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: February 13, 2024
    Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.
    Inventors: Ronggui Yang, Shaoyu Xu, Minghui Wang, Huailun Zhai, Yulei Yan, Zhengjie Yin, Jinling Zhao
  • Publication number: 20240019180
    Abstract: A radiative cooling film and a product thereof are provided. The radiative cooling film includes a carrier layer, a reflective layer and an emissive layer stacked together. A light shines on the radiative cooling film from the emissive layer. The emissive layer includes a polymer containing a C—F bond. The carrier layer includes a polymer containing at least one of a C—C bond and a C—O bond. After disposing at 120 degrees centigrade for 30 minutes, a transverse direction heat-shrinkage rate of the carrier layer is less than or equal to 2%, and a machine direction heat-shrinkage rate of the carrier layer is less than or equal to 3%. A thickness of the radiative cooling film is in a range of 50 ?m to 170 ?m, and a thickness of the emissive layer accounts for 20% to 90% of the thickness of the radiative cooling film.
    Type: Application
    Filed: March 1, 2021
    Publication date: January 18, 2024
    Inventors: Shaoyu XU, Ronggui YANG, Song ZHONG, Minghui WANG, Zhengjie YIN, Huihui YANG, Zhaolu XIA
  • Patent number: 11867434
    Abstract: A radiative cooling film and a product thereof are provided. The radiative cooling film includes a carrier layer, a reflective layer and an emissive layer stacked together. A light shines on the radiative cooling film from the emissive layer. The emissive layer includes a polymer containing a C—F bond. The carrier layer includes a polymer containing at least one of a C—C bond and a C—O bond. After disposing at 120 degrees centigrade for 30 minutes, a transverse direction heat-shrinkage rate of the carrier layer is less than or equal to 2%, and a machine direction heat-shrinkage rate of the carrier layer is less than or equal to 3%. A thickness of the radiative cooling film is in a range of 50 m to 170 ?m, and a thickness of the emissive layer accounts for 20% to 90% of the thickness of the radiative cooling film.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: January 9, 2024
    Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.
    Inventors: Shaoyu Xu, Ronggui Yang, Song Zhong, Minghui Wang, Zhengjie Yin, Huihui Yang, Zhaolu Xia
  • Patent number: 11833780
    Abstract: The present disclosure provides a radiative cooling metal plate, a preparation method and application thereof. The radiative cooling metal plate includes a metal substrate, a first adhesive layer and a radiative cooling functional layer stacked in order, the radiative cooling functional layer is located on a surface of the metal substrate, the first adhesive layer is arranged between the metal substrate and the radiative cooling functional layer, and an elongation at break of the radiative cooling functional layer is in a range of 1% to 300%. The radiative cooling functional layer can have sufficient ductility, and can have sufficient deformation to cope with the bending of the radiative cooling functional layer during pressing, such that the radiative cooling functional layer will not be damaged or broken, thereby ensuring the structural integrity of the radiative cooling functional layer and great radiative cooling effect of the metal substrate.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: December 5, 2023
    Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.
    Inventors: Ronggui Yang, Shaoyu Xu, Zhixiong Chen, Minghui Wang, Huihui Yang, Zhaolu Xia, Peng Cao
  • Patent number: 11780923
    Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: October 10, 2023
    Assignees: Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Xiangdong Qu, Qiyue Hu, Shaoyu Xu, Dongbing Cui, Houcong Jin, Weikang Tao, Lianshan Zhang, Guoqing Cao, Piaoyang Sun
  • Publication number: 20230161085
    Abstract: The present disclosure provides a solar reflecting film and a preparation method thereof. The solar reflecting film includes a substrate and a functional layer stacked on each other. The functional layer includes a first reflecting layer, a barrier layer, and a second reflecting layer stacked on the substrate in order. The barrier layer includes a first barrier layer and a second barrier layer stacked on the first barrier layer. The first barrier layer is metal fluoride, inorganic non-metallic oxide, metal oxide or a combination thereof. The second barrier layer is metal oxides, metal nitrides, semiconductor doped compounds or a combination thereof. And a material of the first barrier layer is at least partially different from that of the second barrier layer.
    Type: Application
    Filed: April 10, 2020
    Publication date: May 25, 2023
    Inventors: Ronggui YANG, Shaoyu XU, Minghui WANG, Huailun ZHAI, Yulei YAN, Zhengjie YIN, Jinling ZHAO
  • Publication number: 20230150242
    Abstract: The present disclosure provides a radiative cooling metal plate, a preparation method and application thereof. The radiative cooling metal plate includes a metal substrate, a first adhesive layer and a radiative cooling functional layer stacked in order, the radiative cooling functional layer is located on a surface of the metal substrate, the first adhesive layer is arranged between the metal substrate and the radiative cooling functional layer, and an elongation at break of the radiative cooling functional layer is in a range of 1% to 300%. The radiative cooling functional layer can have sufficient ductility, and can have sufficient deformation to cope with the bending of the radiative cooling functional layer during pressing, such that the radiative cooling functional layer will not be damaged or broken, thereby ensuring the structural integrity of the radiative cooling functional layer and great radiative cooling effect of the metal substrate.
    Type: Application
    Filed: April 29, 2020
    Publication date: May 18, 2023
    Inventors: Ronggui YANG, Shaoyu XU, Zhixiong CHEN, Minghui WANG, Huihui YANG, Zhaolu XIA, Peng CAO
  • Patent number: 10947394
    Abstract: The present disclosure provides a radiative cooling functional coating material and application thereof. The radiative cooling functional coating material can be configured for manufacturing a radiative cooling functional layer. The radiative cooling functional layer can be configured for reflecting ultraviolet light and/or visible light and/or near-infrared light in sunlight and emitting heat through an atmospheric window in a form of infrared radiation. The radiative cooling functional coating material can include a granular filler and a radiative cooling functional resin, and the granular filler can be distributed in the radiative cooling functional resin.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: March 16, 2021
    Assignees: NINGBO RADI-COOL ADVANCED ENERGY TECHNOLOGIES CO., LTD., NINGBO RUILING ADVANCED ENERGY MATERIALS INSTITUTE CO., LTD.
    Inventors: Shaoyu Xu, Rongbing Wan, Minghui Wang
  • Publication number: 20210002491
    Abstract: The present disclosure provides a radiative cooling functional coating material and application thereof. The radiative cooling functional coating material can be configured for manufacturing a radiative cooling functional layer. The radiative cooling functional layer can be configured for reflecting ultraviolet light and/or visible light and/or near-infrared light in sunlight and emitting heat through an atmospheric window in a form of infrared radiation. The radiative cooling functional coating material can include a granular filler and a radiative cooling functional resin, and the granular filler can be distributed in the radiative cooling functional resin.
    Type: Application
    Filed: September 18, 2019
    Publication date: January 7, 2021
    Inventors: Shaoyu XU, Rongbing WAN, Minghui WANG
  • Publication number: 20200399375
    Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.
    Type: Application
    Filed: August 7, 2020
    Publication date: December 24, 2020
    Inventors: Xiangdong Qu, Qiyue Hu, Shaoyu Xu, Dongbing Cui, Houcong Jin, Weikang Tao, Lianshan Zhang, Guoqing Cao, Piaoyang Sun
  • Patent number: 10815304
    Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: October 27, 2020
    Assignees: Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Xiangdong Qu, Qiyue Hu, Shaoyu Xu, Dongbing Cui, Houcong Jin, Weikang Tao, Lianshan Zhang, Guoqing Cao, Piaoyang Sun
  • Patent number: 10793643
    Abstract: The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: October 6, 2020
    Assignees: Jiangsu Hengrui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Xiangdong Qu, Xin Ye, Shaoyu Xu, Bei Yuan, Dongbing Cui, Qiyue Hu, Lei Zhang, Zhibin Xu, Weikang Tao, Lianshan Zhang, Piaoyang Sun
  • Publication number: 20190016825
    Abstract: The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.
    Type: Application
    Filed: December 20, 2016
    Publication date: January 17, 2019
    Inventors: Xiangdong QU, Xin YE, Shaoyu XU, Bei YUAN, Dongbing CUI, Qiyue HU, Lei ZHANG, Zhibin XU, Weikang TAO, Lianshan ZHANG, Piaoyang SUN
  • Publication number: 20180334504
    Abstract: The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.
    Type: Application
    Filed: November 2, 2016
    Publication date: November 22, 2018
    Applicants: Suzhou Suncadia Biopharmaceuticals Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Xiangdong QU, Qiyue HU, Shaoyu XU, Dongbing CUI, Houcong JIN, Weikang TAO, Lianshan ZHANG, Guoqing CAO, Piaoyang SUN